Answer
Ivosidenib inhibits mutant IDH1, reducing 2-hydroxyglutarate production and restoring cellular differentiation, although its mechanism beyond these effects is not fully understood across indications.
Sources for this answer
- TibsovoServier Laboratories Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 5Document updated
Sources checked